Showing results (51-60 of 95) with videos related to

Sort By:
Pageof 10
Scientific Reports|November 20, 2020
Preemptive interferon-α treatment could protect against relapse and improve long-term survival of ALL patients after allo-HSCTSining Liu, Xueyi Luo, Xiaohui Zhang, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|September 22, 2025
Prognostic value of post-transplantation measurable residual disease in patients with myelodysplastic syndrome: A prospective cohort studyYuewen Wang, Lanping Xu, Yu Wang, et al.
Cell Transplantation|December 16, 2025
Do all roads lead to Rome? The heterogeneity of relapsed/refractory diffuse large B-cell lymphoma patients who achieved therapies response and received autologous stem cell transplantation in the era of new targeted drugsJiangtao Li, Wenxuan Huo, Yang Yang, et al.
Zhonghua Nei Ke Za Zhi|April 25, 2015
[Cytomegalovirus specific cytotoxic T lymphocytes for treatment of refractory cytomegalovirus infection in patients following allogeneic hematopoietic stem cell transplantation]Zhengli Xu, Xiaojun Huang, Yuqian Sun, et al.
British Journal of Haematology|April 26, 2024
Allogeneic haematopoietic stem cell transplantation for adult T-lymphoblastic lymphoma: A real-world multicentre analysis in ChinaWenxuan Huo, Lu Gao, Kaidi Song, et al.
Zhonghua Nei Ke Za Zhi|September 30, 2014
[The risk factors of post-transplant lymphoproliferative disorders following haploidentical hematopoietic stem cell transplantation]Chunli Zhang, Xiaojun Huang, Daihong Liu, et al.
Bone Marrow Transplantation|January 22, 2019
Eltrombopag is an effective and safe therapy for refractory thrombocytopenia after haploidentical hematopoietic stem cell transplantationHaixia Fu, Xiaohui Zhang, Tingting Han, et al.
International Journal of Laboratory Hematology|October 4, 2022
Effects of CD34<sup>+</sup> cell dose on haematopoietic recovery in acute lymphoblastic leukaemia patients with positive pretransplant measurable residual diseaseYuewen Wang, Xiaodong Mo, Yifei Cheng, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|November 14, 2024
Quality-adjusted time without symptoms or toxicity analysis of haploidentical-related donor <i>vs.</i> identical sibling donor hematopoietic stem cell transplantation in acute myeloid leukemiaYuewen Wang, Xianli Gao, Ting Wang, et al.
Zhonghua Nei Ke Za Zhi|February 16, 2016
[A comparison of efficacy and safety of linezolid versus vancomycin for the treatment of infections in patients after allogeneic hematopoietic stem cell transplantation]Jie Tian, Zhengli Xu, Daihong Liu, et al.
Pageof 10